5GOMOLLON F. SICILIA B. Helicobacter pylori, strategies for treatment[J]. Expert Opin Invest Drugs, 2001, 10(7):1231-1241. 被引量：1
6ZHENG PY, HUA J, YEOH KG, et al. Association of peptic ulcer with increased expression of lewis antigens but not cagA, ice Aand vacA in Hclicobacter pylori isolates in an asian population[J].Gut, 2000,47( 1 ) : 18-22. 被引量：1
7NISHIKWA K, SUGIYAMA T, KATO M, et al Non-Helicobecter pylori and non-NSAID peptic ulcer disease in the Japanese population[J]. Eur J Gastroenterol Hepatol, 2000,12(6):635-640. 被引量：1
8MEUCCI G, DI BATTISTA R, ABBIATI C, et al. Prevalence and risk factors of Helicobacter pylori-negative peptic ulcer: a multicenter study[ J ]. J Clin Gastrenterol. 2000,31 ( 1 ) :42-47. 被引量：1
9KAUSHAL S, MIDHA V, SOOD A, et al. A comparative study of the effects of famotidine and sucralfate in prevention of upper gastro-intestinal bleeding in patients of head injury[ J ]. Indian J Pharmacol, 2000,32(3) :246-249. 被引量：1
10XUE S,KATA PO, BANERJEE P, et al. Bedtime H2 blockers improve nocturnal gastric acid control in GERD patients on proton pump inhibitors [ J ]. Aliment Pharmacol Ther, 2001, 15 ( 9 ) :1351-1356. 被引量：1
